Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3
- 22 March 2011
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 162 (8), 1757-1769
- https://doi.org/10.1111/j.1476-5381.2010.01186.x
Abstract
Fenamates are N-phenyl-substituted anthranilic acid derivatives clinically used as non-steroid anti-inflammatory drugs in pain treatment. Reports describing fenamates as tools to interfere with cellular volume regulation attracted our attention based on our interest in the role of the volume-modulated transient receptor potential (TRP) channels TRPM3 and TRPV4. Firstly, we measured the blocking potencies and selectivities of fenamates on TRPM3 and TRPV4 as well as TRPC6 and TRPM2 by Ca(2+) imaging in the heterologous HEK293 cell system. Secondly, we further investigated the effects of mefenamic acid on cytosolic Ca(2+) and on the membrane voltage in single HEK293 cells that exogenously express TRPM3. Thirdly, in insulin-secreting INS-1E cells, which endogenously express TRPM3, we validated the effect of mefenamic acid on cytosolic Ca(2+) and insulin secretion. We identified and characterized mefenamic acid as a selective and potent TRPM3 blocker, whereas other fenamate structures non-selectively blocked TRPM3, TRPV4, TRPC6 and TRPM2. This study reveals that mefenamic acid selectively inhibits TRPM3-mediated calcium entry. This selectivity was further confirmed using insulin-secreting cells. K(ATP) channel-dependent increases in cytosolic Ca(2+) and insulin secretion were not blocked by mefenamic acid, but the selective stimulation of TRPM3-dependent Ca(2+) entry and insulin secretion induced by pregnenolone sulphate were inhibited. However, the physiological regulator of TRPM3 in insulin-secreting cells remains to be elucidated, as well as the conditions under which the inhibition of TRPM3 can impair pancreatic β-cell function. Our results strongly suggest mefenamic acid is the most selective fenamate to interfere with TRPM3 function.Keywords
This publication has 61 references indexed in Scilit:
- TRPMLs: in sickness and in healthAmerican Journal of Physiology-Renal Physiology, 2009
- TRPM2 Functions as a Lysosomal Ca 2+ -Release Channel in β CellsScience Signaling, 2009
- TRPA1 and Cold Transduction: An Unresolved Issue?The Journal of general physiology, 2009
- Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation*Journal of Biological Chemistry, 2008
- Arterial Response to Shear Stress Critically Depends on Endothelial TRPV4 ExpressionPLOS ONE, 2007
- Non‐steroidal anti‐inflammatory drugs increase insulin release from beta cells by inhibiting ATP‐sensitive potassium channelsBritish Journal of Pharmacology, 2007
- Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channelsProceedings of the National Academy of Sciences of the United States of America, 2006
- Inhibition of TRPM2 cation channels by N‐(p‐amylcinnamoyl)anthranilic acidBritish Journal of Pharmacology, 2006
- TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretionThe EMBO Journal, 2006
- TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionNature Genetics, 2005